PMC:7784786 / 6453-6580 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"234","span":{"begin":21,"end":31},"obj":"Chemical"}],"attributes":[{"id":"A234","pred":"tao:has_database_id","subj":"234","obj":"MESH:C000597346"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Patient 1 (A) Before itolizumab (D0): diffuse Interstitial-alveolar infiltrate in both lung fields, predominantly in the bases."}

{"project":"LitCovid-sentences","denotations":[{"id":"T59","span":{"begin":0,"end":127},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Patient 1 (A) Before itolizumab (D0): diffuse Interstitial-alveolar infiltrate in both lung fields, predominantly in the bases."}